-
Your Voice Can Shape Clinical Trials | Participate for $100 gift card!
Researchers at Mass General Brigham, Dana-Farber, and Harvard Medical School are exploring how AI chatbots can make clinical trial consent easier to understand. They’re inviting adult cancer patients across the U.S. to join a virtual focus group and share their ideas. Participants will receive a $100 gift card. Spots are…
-
What topics/experts would you like to see on The Breastcancer.org Podcast?
Hello, I'm Jamie, senior editor at Breastcancer.org and host of The Breastcancer.org Podcast. I'd like to make sure the podcast is answering questions that Community members have. Are there topics you'd like to see covered? Experts you think I should talk to? Do you want to share your story? Questions you want answered?…
-
Breastcancer.org Podcasts: Experts discuss research & issues
Our podcasts feature experts discussing a wide variety of breast cancer issues and the latest research on breast cancer. Check out all of Breastcancer.org's Podcasts here. In the premiere podcast, we're excited to bring you a summary of the research highlights from first day of the San Antonio Breast Cancer Symposium 2013!…
-
Breaking Research News from Breastcancer.org
Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU. Favorite this thread to get notifications on all the breaking news about current breast cancer…
-
Breastcancer.org News Hub
Check out our reporting on trending breast cancer news in our one-of-a-kind and frequently updated News Hub: https://www.breastcancer.org/news
-
Top Breast Cancer Research in 2024
Please check out our coverage of all the important research we've covered this year! https://www.breastcancer.org/news/top-breast-cancer-research-of-2024
-
Breastcancer.org Research Conferences Coverage
Breastcancer.org is dedicated to bringing you the latest in breast cancer research by sending our reporters to get boots-on-the-ground breaking information at annual breast cancer conferences whenever possible. Here, we'll share our coverage and this thread will be updated as necessary in real time — make sure to bookmark…
-
Dana Farber 2022-2023 EMBRACE MBC Virtual Forum Series
Hi all! We wanted to share with you a helpful series of five free online virtual forums about promising areas of research and treatment in metastatic breast cancer hosted by Dana Farber's 2022-2023 EMBRACE MBC program. You can access the recordings here: * Welcome Session | 2022-2023 EMBRACE MBC Virtual Forum Series *…
-
Studies that prove early detection of stage IV recurrence extending survival time?
Can you please point me to any studies that show that early detection of metastatic stage IV breast cancer results in longer survival ? If this matters, I'm talking about ER+. HER2-. I know that it's a common opinion that early detection of such recurrence does not result in longer life, but are there any studies that…
-
Moved: Fenbendazole, Ivermectin, Mebendazole, Methylene blue for Breast Cancer
This discussion has been moved.
-
Dr. Kerry Courneya will be guest on The Breastcancer.org Podcast. Do you have questions?
Dr. Courneya was the lead investigator of the CHALLENGE trial, which found that a three-year exercise program after chemotherapy for stage III colon cancer improved both disease-free and overall survival. This is the firs time a study showed that exercise improved overall survival. Dr. Courneya thinks the results may have…
-
SBRT vs. Histrotripsy for Liver Mets
Hello, I am weighing the options of treating my liver mets with either histotripsy or SBRT. I am in communication with 2 different physicians, one who treats with histotripsy and the other with SBRT. The physician that uses histotripsy is still in the process of reviewing my images, and is expected to contact me soon as to…
-
Teaching the Immune System to Fight Cancer
Aug 22, 2025 A new type of drug may be able to make the immune system attack cancer. Dr. Benjamin Schrank explains his research. Antibody-drug conjugates (ADCs) are a relatively new type of medicine for breast cancer. Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Dato-DXd (brand name: Datroway) are two ADCs…
-
Alisertib clinical trial at Mayo
I am starting a clinical trial next week for Alisertib (plus Fluvestrant) and I would love to hear people's experience with Alisertib. I was diagnosed Stage 4 in May and this will be my second line of treatment (Kisqali didn't work for me.) I have mets in my liver, lungs, bones and lymph nodes.…
-
Debra Trails...
Anyone have any thoughts, information, etc. on the Debra trails. I have googled it and am continuing to search for as much detail as I can find. I have IDC Grade 1, HR+, Her- and my tumor was less than 5mm. This is a very personal decision, but trying to gather as much information as I can prior to making my decision.
-
Top Breast Cancer Research at ASCO 2025
Top Breast Cancer Research at ASCO 2025 Dr. Eleonora Teplinsky explains DESTINY-Breast09, ASCENT-04, and SERENA-6. Jun 2, 2025 The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified…
-
Winter 2025 Breast Cancer Research Round Up
Winter 2025 Breast Cancer Research Round Up Have you been diagnosed with metastatic hormone receptor-positive breast cancer or DCIS? Dr. Kevin Fox discusses the latest research. Apr 18, 2025 Can people diagnosed with metastatic hormone receptor-positive breast cancer avoid chemotherapy and take a CDK4/6 inhibitor instead?…
-
How Is the NIH Funding Freeze Affecting Breast Cancer Research? One Scientist Explains
How Is the NIH Funding Freeze Affecting Breast Cancer Research? One Scientist Explains Noted scientist Donald McDonnell explains how the halt in NIH funding is hampering breast cancer research. Mar 21, 2025 The National Institutes of Health (NIH) are the largest funder of cancer research in the world. A January 2025…